Document is current
Any future updates will be listed below
-
Authors
Sugawara, Yuka
Kato, Hideki
Nagasaki, Masao https://orcid.org/0000-0002-4292-8785
Yoshida, Yoko
Fujisawa, Madoka
Minegishi, Naoko
Yamamoto, Masayuki https://orcid.org/0000-0002-9073-9436
Nangaku, Masaomi
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (17ek0109254h0001, 17ek0109254h0001, 17ek0109254h0001, 17ek0109254h0001, 17ek0109254h0001, 17ek0109254h0001, 17ek0109254h0001, 17ek0109254h0001)
the Japanese association for complement research
- License Information
-
More Information
Article History
Received: 1 June 2022
Revised: 26 January 2023
Accepted: 30 January 2023
First Online: 9 February 2023
Competing interests
: Masaomi Nangaku receives honoraria for lectures from Alexion Pharma and honoraria for lectures and subsidies from Chugai Pharma.
